香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並表明概不就因本公告之全部或任何部份內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 EC Healthcare 醫思健康（「本公司」）之董事會（「董事會」）謹此宣佈，本公司將於二零二五年 十一月二十八日（星期五）舉行董事會會議，藉以（其中包括）考慮及批准本公司及 其附屬公司截至二零二五年九月三十日止六個月之中期業績及考慮派發中期股息 （如 有）。 承董事會命 醫思健康 公司秘書 蕭鎮邦 香港，二零二五年十一月十七日 醫思健康 (於開曼群島註冊成立之有限公司) (股份代號：2138) 董事會會議日期 於本公告日期，執行董事為鄧志輝先生、呂聯煒先生及李向榮先生；非執行董事為陸韵晟 先生及梁楊世嫡女士；以及獨立非執行董事為馬清楠先生、陸東先生及區雋先生。 ...

Group 1: Aviation Training Technology - The full-motion flight simulator visual system, developed by Tencent and Southern Airlines, represents a breakthrough in key aviation technology in China, completing a generational upgrade of the simulator visual system [1] - The system has achieved high-precision 3D reconstruction of over 200 airports globally, covering major international aviation hubs, providing efficient and safe training support for nearly 90,000 civil aviation pilots in China [1] Group 2: AI Safety Solutions - 360 has developed a large model security guard based on the "model-based modeling" concept, focusing on addressing AI's reliability, trustworthiness, controllability, and benevolence issues [2] - The solution includes a standardized and automated evaluation process, multi-dimensional verification of business model outputs, and dual protection on input and output sides, enabling "plug-and-play" security enhancements [2] Group 3: AI in Industry Solutions - iFLYTEK launched the Xinghuo cognitive large model, which possesses capabilities in text generation, language understanding, logical reasoning, and multimodal processing, continuously evolving from vast data and knowledge [3] - The model effectively addresses key challenges in complex scenarios across various vertical industries [3] Group 4: AI-Driven Business Solutions - Baidu's Huibo Star is the first AI full-stack digital human solution in the industry, leveraging generative AI technologies to empower live streaming, lead collection, and content broadcasting, helping businesses achieve low-threshold, round-the-clock live streaming [4] - The AI video generation platform allows users to quickly capture real-time trends and automatically generate video scripts, facilitating efficient digital human video creation [4] Group 5: Smart Supply Chain in Automotive Industry - JD's industrial solution for the automotive sector promotes the digital transformation of the supply chain, aiming to create a resilient and efficient automotive supply chain system [5] - The solution is expected to reduce supplier management costs by over 50% and improve supply chain response speed by 30% [5] Group 6: AI in Media Innovation - Kuaishou is expanding application scenarios around its AI technology, enhancing media production, advertising creativity, and gaming through collaborations [6] - The company has established a comprehensive AI ecosystem with a matrix of large models, injecting new momentum into smart media development [6] Group 7: Digital Cultural Promotion - Meitu has initiated a "Digital Communication Project for Chinese Traditional Culture," creating a "Guochao Pattern" brand that transforms traditional patterns into creative materials, enhancing young people's recognition and participation in traditional culture [8] - The project has achieved over 2 billion transmissions and created more than 100 sets of Guochao pattern materials, revitalizing traditional culture among the younger generation [8] Group 8: Smart Healthcare Ecosystem - Ant Group's digital healthcare business has served over 800 million users since its launch in 2014, collaborating with over 3,600 medical institutions to promote the digital upgrade of medical payments and health services [9] - The initiative aims to enhance the accessibility and convenience of public health management through a dual-driven approach of technology and ecosystem [9] Group 9: Autonomous Delivery Solutions - Meituan is focusing on breakthroughs in autonomous delivery technology and its commercialization, collaborating with Tsinghua University to establish a research center for intelligent driving in urban complex scenarios [10] - The initiative aims to improve delivery efficiency and user experience while reducing costs in urban logistics [10] Group 10: Humanistic AI Development - Xiaohongshu plans to upgrade its internal large model technology and application product team into a humanistic intelligence laboratory, inviting researchers with humanistic backgrounds to enhance AI with human wisdom and values [11] - The team aims to integrate humanities thinking with natural language processing to shape AI's personality and values, improving its empathy and value judgment capabilities in complex situations [11]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年10月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 醫思健康 | | | | | | 呈交日期: | 2025年11月3日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02138 | 說明 | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 上月底結存 | 38,000,000,000 | HKD | | 0.00001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | | | HKD | | | | 本月底結存 | 3 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 醫思健康 | | | | | | 呈交日期: | 2025年10月8日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02138 | 說明 | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | --- | --- | --- | --- | --- | --- | --- | | 上月底結存 | | 38,000,000,000 HKD | | 0.00001 | HKD | 380,000 | | 增加 / 減少 (-) | | | | | HKD | | | 本月底結存 | | 38,000,000,0 ...

| 截至月份: | 2025年8月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 醫思健康 | | | | | | 呈交日期: | 2025年9月3日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02138 | 說明 | | | | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | --- | --- | --- | --- | --- | --- | --- | | 上月底結存 | | 38,000,000,000 | HKD | 0.00001 | HKD | 380,000 | | 增加 / 減少 (-) | | | | | HKD | | | 本月底結存 | | 38,000,000,00 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並表明概不就因本公告之全部或任何部份內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 EC Healthcare 醫思健康 （於開曼群島註冊成立之有限公司） （股份代號：2138） 於二零二五年八月二十二日舉行之 股東週年大會之投票結果 除非文義另有所指，本公佈所用詞彙與二零二五年七月三十一日之本公司通函（「通函」）所 界定者具相同涵義。 股東週年大會出席人士 於股東週年大會當日，本公司之已發行股本（「股份」）為1,185,211,265股股份，此乃賦予持 有人權利出席股東週年大會，並於會上表決贊成或反對所有決議案之股份總數。持有 708,220,934 股股份總數（佔股份總數的 59.75%）的股東（親身出席或委託代理人）出席了股 東週年大會。 概無任何股份賦予持有人權利出席股東週年大會但根據香港聯合交易所有限公司證券上市規則 （「上市規則」）第 13.40 條所載須放棄表決贊成決議案，亦無任何股份其持有人須根據上市 規則規定於股東週年大會上放棄表決權。概無本公司之股東於通函中表示有意在股 ...

Core Viewpoint - Medical technology company, Yisi Health (02138), has seen its stock price increase by over 70% in the last three trading days, with a current price of 1.09 HKD and a trading volume of 14.21 million HKD [1] Group 1: Strategic Partnership - In May, Yisi Health and Yimai Sunshine held a strategic cooperation signing ceremony in Hong Kong, establishing the "Yimai Yisi Health Technology Alliance" [1] - The partnership aims to create a dual-engine supply chain platform combining "centralized procurement + global distribution" [1] - The joint venture will integrate Yimai Sunshine's strengths in medical imaging equipment, supply chain, and department operation management with Yisi Health's channel resources in Hong Kong, Macau, and overseas markets [1] Group 2: Company Profile - Yisi Health is the largest non-hospital medical service supplier in Hong Kong, focusing on precision and preventive healthcare [1] - The company aims to become a leading one-stop health ecosystem, providing comprehensive medical services including health checks, vaccinations, laboratory testing, imaging diagnostics, primary care, specialist consultations, dental care, and pain management [1]

Core Viewpoint - Medical Mind Health (02138) has seen a significant stock price increase of over 70% in the last three trading days, with a current price of 1.09 HKD and a trading volume of 14.21 million HKD [1] Group 1: Strategic Partnership - In May of this year, Yimai Sunshine and Medical Mind Health held a strategic cooperation signing ceremony in Hong Kong, officially establishing the "Yimai Medical Mind Health Technology Alliance" [1] - The partnership aims to create a dual-engine supply chain platform combining "centralized procurement + global distribution" [1] - The joint venture will integrate Yimai Sunshine's core advantages in medical imaging equipment, supply chain of consumables, and department operation management with Medical Mind Health's channel resources in Hong Kong, Macau, and overseas markets [1] Group 2: Company Overview - Medical Mind Health is the largest non-hospital medical service supplier in Hong Kong, focusing on precision and preventive healthcare [1] - The company aims to become a leading one-stop health ecosystem, providing comprehensive medical services including health checks, vaccination, laboratory testing, imaging diagnostics, primary care, specialist consultations, dental services, and pain management [1]

Company Overview - Medical Health is the largest non-hospital medical service provider in Hong Kong, focusing on preventive and precision medicine, aiming to create a leading one-stop health ecosystem [4] - The company offers a comprehensive range of medical services, including health checks, vaccination, laboratory testing, imaging diagnostics, primary care, specialist consultations, dental care, and pain management [4] - Medical Health operates 182 service points across approximately 657,000 square feet and has 46 diversified brands to cater to both high-end and mass-market needs [4] Financial Performance - As of March 31, 2025, Medical Health reported total revenue of 3.821 billion yuan, a year-on-year decrease of 1.68% [2] - The company recorded a net loss attributable to shareholders of 154 million yuan, a significant year-on-year decrease of 782.39% [2] - The gross profit margin stands at 80.73%, with a debt-to-asset ratio of 56.14% [2] Market Position and Valuation - Medical Health's price-to-earnings (P/E) ratio is -4.82, ranking 91st in the healthcare equipment and services industry, which has an average P/E ratio of 0.69 and a median of 1.36 [3] - The stock has seen a cumulative increase of 19.3% over the past month, but only 1.49% year-to-date, underperforming the Hang Seng Index, which has risen by 27.22% [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年7月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 醫思健康 | | | | | | 呈交日期: | 2025年8月6日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02138 | 說明 | | | | | | 法定/註冊股份數目 | | | 面值 | 法定/註冊股本 | | | --- | --- | --- | --- | --- | --- | --- | | 上月底結存 | | 38,000,000,000 | HKD | 0.00001 HKD | | 380,000 | | 增加 / 減少 (-) | | | | HKD | | | | 本月底結存 | | 38,000,000,00 ...